QUIDELORTHO CORP (QDEL) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-28..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-28..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-28..
Borrowing debt
Overview →Financial period ending 2026-06-28; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-28. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-28. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-28. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 355.70M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities |
| Total assets | 5.72B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | (m) | (m) | $355.70M | (m) | (m) | (m) | $5.72B | (m) |
| 2026-03-29 | (m) | (m) | $228.20M | (m) | (m) | (m) | $5.63B | (m) |
| 2025-12-28 | (m) | (m) | $178.30M | (m) | (m) | (m) | $5.77B | (m) |
| 2025-09-28 | (m) | (m) | $162.50M | (m) | (m) | (m) | $5.68B | (m) |
| 2025-06-29 | (m) | (m) | $534.20M | (m) | (m) | (m) | $6.38B | (m) |
| 2025-03-30 | (m) | (m) | $393.80M | (m) | (m) | (m) | $6.46B | (m) |
| 2024-12-29 | (m) | (m) | $341.80M | (m) | (m) | $98.30M | $6.42B | (m) |
| 2024-09-29 | (m) | (m) | $373.80M | (m) | (m) | $143.70M | $6.80B | (m) |
| 2024-06-30 | (m) | (m) | $356.40M | (m) | (m) | $107.00M | $6.69B | (m) |
| 2024-03-31 | (m) | (m) | $161.10M | (m) | (m) | $78.50M | $6.70B | (m) |
| 2023-12-31 | (m) | (m) | $139.80M | (m) | (m) | $167.30M | $8.56B | (m) |
| 2023-10-01 | (m) | (m) | $193.00M | (m) | (m) | $193.20M | $8.54B | (m) |
| 2023-07-02 | (m) | (m) | $207.40M | (m) | (m) | $223.70M | $8.55B | (m) |
| 2023-04-02 | (m) | (m) | $207.50M | (m) | (m) | $396.70M | $8.79B | (m) |
| 2023-01-01 | (m) | (m) | $207.50M | (m) | (m) | $345.00M | $8.86B | (m) |
| 2022-10-02 | (m) | (m) | $207.60M | (m) | (m) | $264.00M | $8.66B | (m) |
| 2022-07-03 | (m) | (m) | $207.80M | (m) | (m) | $431.50M | $8.82B | (m) |
| 2022-01-02 | (m) | (m) | $300.00K | (m) | (m) | $828.50M | $2.43B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |